Insider holders · CIK 0001438533
Travere Therapeutics, Inc. · TVTX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Kevin Kotler10% Owner | 2,658,854 | — | 2,658,854 | Jan 30, 2015 · 2:43 pm EST | Form 3 |
| Broadfin Capital, LLC10% Owner | 2,658,854 | — | 2,658,854 | Jan 30, 2015 · 2:43 pm EST | Form 3 |
| Broadfin Healthcare Master Fund Ltd10% Owner | 2,658,854 | — | 2,658,854 | Jan 30, 2015 · 2:43 pm EST | Form 3 |
| Eric M DubeCHIEF EXECUTIVE OFFICER | 432,886 | — | 432,886 | Sep 17, 2026 · 9:31 pm EDT | Form 4 |
| Steve AselageChief Executive Officer | 257,642 | — | 257,642 | Feb 13, 2019 · 8:47 pm EST | Form 4 |
| Alvin ShihEVP of Research & Development | 158,334 | — | 158,334 | Sep 2, 2016 · 9:26 pm EDT | Form 4 |
| Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | 117,066 | — | 117,066 | Sep 17, 2026 · 9:35 pm EDT | Form 4 |
| Elizabeth E ReedChief Legal Officer and GC | 105,389 | — | 105,389 | Sep 17, 2026 · 9:32 pm EDT | Form 4 |
| Jula InrigEVP, Head of R&D & CMO | 100,491 | — | 100,491 | Sep 17, 2026 · 9:33 pm EDT | Form 4 |
| Jensen Margaret E ValeurGeneral Counsel | 100,000 | — | 100,000 | Feb 2, 2016 · 6:49 pm EST | Form 4 |
| William E. RoteChief Research Officer | 98,197 | — | 98,197 | Sep 17, 2026 · 9:35 pm EDT | Form 4 |
| Jeffrey A MecklerDirector | 91,500 | — | 91,500 | Sep 11, 2026 · 4:05 pm EDT | Form 4 |
| Christopher R. ClineCHIEF FINANCIAL OFFICER | 87,508 | — | 87,508 | Sep 17, 2026 · 9:30 pm EDT | Form 4 |
| Gary A LyonsDirector | 61,500 | — | 61,500 | Aug 19, 2026 · 4:05 pm EDT | Form 4 |
| Timothy CoughlinDirector | 56,250 | — | 56,250 | Jun 16, 2026 · 4:46 pm EDT | Form 4 |
| Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | 42,353 | — | 42,353 | Sep 17, 2026 · 9:29 pm EDT | Form 4 |
| Roy D. BaynesDirector | 41,500 | — | 41,500 | Jun 16, 2026 · 4:42 pm EDT | Form 4 |
| Cornelius E GoldingDirector | 29,000 | — | 29,000 | May 19, 2016 · 1:33 pm EDT | Form 4 |
| Neil F. McFarlaneChief Operating Officer | 28,956 | — | 28,956 | Dec 21, 2018 · 8:21 pm EST | Form 4 |
| John W KozarichDirector | 27,000 | — | 27,000 | May 11, 2018 · 9:09 pm EDT | Form 4 |
| Noah L. RosenbergChief Medical Officer | 10,000 | — | 10,000 | Jul 30, 2018 · 8:08 pm EDT | Form 4 |
| Laura ClagueChief Financial Officer | 10,000 | — | 10,000 | Feb 13, 2019 · 8:49 pm EST | Form 4 |
| John A OrwinDirector | 6,875 | — | 6,875 | May 11, 2018 · 9:12 pm EDT | Form 4 |
| Ron SquarerDirector | 6,875 | — | 6,875 | May 11, 2018 · 9:11 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.